Tech Company Financing Transactions

Rallybio Funding Round

On 4/26/2018, Rallybio raised $37 million in Series A funding from 5AM Ventures, Canaan Partners and New Leaf Venture Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

400 Farmington Ave. R2818
Farmington, CT 06032
USA

Phone

(203) 859-3820

Website

www.rallybio.com

Email Address

Not Recorded

Overview

Rallybio is a privately-held early-stage biotechnology company incorporated in January 2018. Our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Co-Founder

Jeffrey Fryer

        

Co-Founder

Martin Mackay

        

Co-Founder

Stephen Uden

        

Browse more venture capital transactions:

Prev: 4/26/2018: leaseABLE venture capital transaction
Next: 4/26/2018: Innovium venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary